Description: Bio-Gene Technology Limited is an Australia-based biotechnology company. The Company is focused on developing and enabling the next generation of novel insecticides to address of insecticide resistance and toxicity. Its novel platform technology is based on a naturally occurring class of chemicals known as beta-triketones. The Company’s products include Flavocide and Qcide. The Flavocide product is based on a class of chemistry identified in extracts of specific Australian native flora. It is based on flavesone, a chemically synthesised nature-identical compound. The Qcide is extracted from the leaves of a rare sub-set of eucalyptus trees which are grown in controlled farming systems by sub-contractors to bio-gene.
Home Page: www.bio-gene.com.au
BGT Technical Analysis
456 Lonsdale Street
Melbourne,
VIC
3000
Australia
Phone:
61 3 9068 1062
Officers
| Name | Title |
|---|---|
| Mr. Richard Andrew Jagger B.Sc., BSC (HONS), GAICD, M.INTL.BUS | MD, CEO & Director |
| Mr. Roger McPherson C.P.A., CPA, B.Bus, GAICD | CFO & Company Sec. |
| Mr. Peter Donald May AFA1M, AFAIM, GAICD, M.B.A., MBA | Exec. Director of R&D and Exec. Director |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Chemicals |
| GIC Sub-Industry: | Fertilizers & Agricultural Chemicals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.1421 |
| Price-to-Sales TTM: | 42.1806 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |